1. Kai Xin San ameliorates scopolamine-induced cognitive dysfunction
    Shi-Jie Zhang et al, 2019, Neural Regeneration Research CrossRef
  2. Kaixinsan, a Well-Known Chinese Herbal Prescription, for Alzheimer's Disease and Depression: A Preclinical Systematic Review
    Huan Fu et al, 2020, Frontiers in Neuroscience CrossRef
  3. Systematic review of Kaixinsan in treating depression: Efficacy and pharmacological mechanisms
    Menghan Bo et al, 2022, Frontiers in Behavioral Neuroscience CrossRef
  4. Potential effect of herbal antidepressants on cognitive deficit: Pharmacological activity and possible molecular mechanism
    Jian-Mei Li et al, 2020, Journal of Ethnopharmacology CrossRef
  5. A randomized, placebo-controlled, double-blind study on the effects of SZL on patients with mild to moderate depressive disorder with comparison to fluoxetine
    Yuan Hu et al, 2021, Journal of Ethnopharmacology CrossRef
  6. Network Pharmacology and Molecular Docking Analysis on Molecular Targets and Mechanisms of Buyang Huanwu Decoction in the Treatment of Ischemic Stroke
    Qiang Gao et al, 2021, Evidence-Based Complementary and Alternative Medicine CrossRef
  7. Chinese Medicine: A Hope for Neurodegenerative Diseases?
    Betty Yuen Kwan Law et al, 2017, Journal of Alzheimer's Disease CrossRef
  8. Study on the Multitarget Synergistic Effects of Kai-Xin-San against Alzheimer’s Disease Based on Systems Biology
    Sirui Guo et al, 2019, Oxidative Medicine and Cellular Longevity CrossRef
  9. Kaixin Jieyu Granule attenuates neuroinflammation-induced depressive-like behavior through TLR4/PI3K/AKT/FOXO1 pathway: a study of network pharmacology and experimental validation
    Manman Xu et al, 2023, BMC Complementary Medicine and Therapies CrossRef
  10. Rapid discovery of quality-markers from Kaixin San using chinmedomics analysis approach
    Xi-jun Wang et al, 2019, Phytomedicine CrossRef
  11. Efficacy of Chinese herbal formula Kai-Xin-San on rodent models of depression: A systematic review and meta-analysis
    Ya-Ting Wang et al, 2024, Journal of Ethnopharmacology CrossRef
  12. Anti-depressive effects of Kai-Xin-San on lipid metabolism in depressed patients and CUMS rats using metabolomic analysis
    Xiaojiang Zhou et al, 2020, Journal of Ethnopharmacology CrossRef
  13. High‐throughput lipidomics analysis to discover lipid biomarkers and profiles as potential targets for evaluating efficacy of Kai‐Xin‐San against APP/PS1 transgenic mice based on UPLC–Q/TOF–MS
    Ai‐hua Zhang et al, 2020, Biomedical Chromatography CrossRef
  14. Behavioral and Biochemical Effects of KXS on Postmyocardial Infarction Depression
    Yuan Hu et al, 2020, Frontiers in Pharmacology CrossRef
  15. Cystatin C prevents neuronal loss and behavioral deficits via the endosomal pathway in a mouse model of down syndrome
    Gurjinder Kaur et al, 2018, Neurobiology of Disease CrossRef
  16. Memory impairment of chewing-side preference mice is associated with 5-HT-BDNF signal pathway
    Hua Jiang et al, 2021, Molecular and Cellular Biochemistry CrossRef
  17. Quercetin attenuates brain apoptosis in mice with chronic unpredictable mild stress-induced depression
    Chenjie Ge et al, 2024, Behavioural Brain Research CrossRef
  18. Chinese traditional formula Kaixin San suppressed ferroptosis of hippocampal neurons and cardiomyocytes in mice with paradoxical sleep deprivation
    Yin Cao et al, 2023, Journal of Ethnopharmacology CrossRef